Denovo Ventures

About The Fund

DeNovo Ventures is a venture capital firm established in 2000 with a focus on investing in the medical devices and biotechnology sectors. With $650 million under management, DeNovo Ventures has established itself as a significant player in the healthcare investment landscape, boasting over 40 investments across three funds. The firm's investment portfolio encompasses a wide range of enterprise development stages, from early to late-stage companies. DeNovo’s team is composed of seasoned investors and experienced medical device entrepreneurs, which provides the firm with a unique combination of skills and perspectives. The team's background includes leading companies as entrepreneurs and operating executives from their inception to their exit, granting DeNovo the expertise to advise entrepreneurs and management teams throughout the company's lifecycle. The firm’s success is attributed to its commitment to building companies that not only have a meaningful clinical impact but also generate superior returns for its stakeholders. Although the firm has a history in medical-focused investments, its investment interests also span across various other industries, including Software, IT and TMT, Education, Business Solutions, FinTech and Financial Services, Hardware and Manufacturing, and Life Science. Their approach integrates a blend of both early and later-stage funding strategies, ensuring a tailored investment approach that aligns with the specific growth phases and requirements of their portfolio companies. DeNovo Ventures believes in leveraging its experience in creating value and providing strategic guidance to foster innovation and growth in promising ventures.